Summary & Overview
HCPCS G9171: Voice Functional Limitation Assessment
HCPCS Level II code G9171 identifies documentation of voice functional limitation at the start of a therapy episode and at reporting intervals to capture changes during speech-language pathology services. Nationally, standardized functional-status codes such as G9171 support consistent outcome measurement, quality reporting, and value-based arrangements by providing a structured way to record patient-reported or clinician-assessed vocal impairment over time.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent and service context, typical sites where it is used, and the types of reporting and benchmarking frameworks that reference functional-status codes. The publication also outlines common documentation expectations, reporting intervals implied by the code description, and the role of G9171 in outcome tracking for voice therapy programs.
This summary is oriented for clinicians, billing professionals, and policy analysts seeking a national-level reference on how G9171 functions within clinical workflows and payer reporting frameworks. Data not available in the input will be identified where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code G9171 denotes voice functional limitation, current status at therapy episode outset and at reporting intervals. This code is used to document patients' baseline vocal function and to track changes over the course of speech-language pathology or voice therapy interventions.
Service Type: Speech-language pathology / voice therapy assessment and outcome tracking
Typical Site of Service: Outpatient clinics, rehabilitation centers, and other ambulatory care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old professional singer presenting to outpatient speech-language pathology with progressive hoarseness, reduced vocal endurance, and decreased pitch control for 3 months following an upper respiratory infection. The otolaryngologist documents vocal fold swelling and refers the patient for voice therapy. At the start of the therapy episode the speech-language pathologist performs a baseline voice functional limitation assessment to quantify current status using validated measures (e.g., Voice Handicap Index, auditory-perceptual ratings, maximum phonation time, and connected speech assessment). The clinician documents severity and activity/participation limitations, sets measurable functional goals, and records the baseline using billing code G9171. Re-assessments using the same standardized measures occur at regular reporting intervals (for example, every 4–6 weeks or at defined episode milestones) to document change in voice function and to support continued medical necessity for ongoing therapy. Typical workflow includes initial evaluation with otolaryngology findings, baseline functional measurement and treatment planning by the speech-language pathologist, periodic progress reporting using G9171 at established intervals, and discharge summary documenting final status and outcomes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 |